What does cancer stage mean, and why is the TNM classification important?

2026-09-15

Cancer staging refers to the determination of the extent of neoplastic disease in the body at the time of diagnosis or surgery. The most widely used international system is the TNM system maintained by the UICC and the AJCC. The acronym denotes three fundamental anatomical factors: T (Tumour, the size of the primary tumour and its extent of invasion into immediately adjacent structures), N (Node, the involvement of regional lymph nodes), and M (Metastasis, the presence or absence of distant metastases). The TNM classification is of paramount importance because it provides a shared international professional language for clinicians, fundamentally determines the therapeutic strategy (such as resectability, or the need for neoadjuvant or adjuvant oncological treatments), provides prognostic information regarding the expected outcome, and enables the standardised comparison of clinical trial results and registry data.\n\nOverall stage groups (typically from 0 to IV) are derived from the combination of TNM categories, distinguishing early, localised processes (I–II) from locally advanced or lymph node-positive (III) and distant metastatic (IV) diseases. In addition to anatomical extent, modern guidelines (such as the 8th and 9th editions of the AJCC and UICC) increasingly integrate supplementary pathological and molecular prognostic factors as well.

References

  1. Cancer staging data collection using rules-based natural language processing for entity extraction from pathology notifications: the WA cancer staging project. PMID 42298565
  2. The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change. PMID 42261202
  3. Availability of Stage Information From Cancer Registries Providing Data to the European Cancer Information System for Six Selected Cancers. PMID 42298920
  4. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging PMID 28094848
  5. PMID 28094848

QA